The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(methoxy(naphthalen-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid ID: ALA5074808
PubChem CID: 166636637
Max Phase: Preclinical
Molecular Formula: C20H16N2O3
Molecular Weight: 332.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CO[C@@H](c1ccc2ccccc2c1)c1nc2ccc(C(=O)O)cc2[nH]1
Standard InChI: InChI=1S/C20H16N2O3/c1-25-18(14-7-6-12-4-2-3-5-13(12)10-14)19-21-16-9-8-15(20(23)24)11-17(16)22-19/h2-11,18H,1H3,(H,21,22)(H,23,24)/t18-/m0/s1
Standard InChI Key: KDXSNPORUZKDLF-SFHVURJKSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.8340 -10.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8328 -11.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5409 -12.2275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5391 -10.5902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2477 -10.9954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2480 -11.8141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0266 -12.0668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5077 -11.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0262 -10.7423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3249 -11.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7337 -12.1116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7332 -10.6962 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3217 -12.8159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9561 -12.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5456 -12.1061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5504 -10.6959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1262 -10.5906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1260 -9.7734 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4186 -10.9994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5479 -13.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7338 -13.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3277 -14.2254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7344 -14.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5516 -14.9275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9541 -14.2235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
8 10 1 0
10 11 1 0
10 12 1 1
11 13 2 0
13 21 1 0
20 14 1 0
14 15 2 0
15 11 1 0
12 16 1 0
1 17 1 0
17 18 1 0
17 19 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 20 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 332.36Molecular Weight (Monoisotopic): 332.1161AlogP: 4.15#Rotatable Bonds: 4Polar Surface Area: 75.21Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.95CX Basic pKa: 4.79CX LogP: 2.65CX LogD: 0.50Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.59Np Likeness Score: -0.61
References 1. Rübbelke M, Hamilton J, Binder F, Bauer M, King J, Nar H, Zeeb M.. (2021) Discovery and Structure-Based Optimization of Fragments Binding the Mixed Lineage Kinase Domain-like Protein Executioner Domain. , 64 (21.0): [PMID:34672548 ] [10.1021/acs.jmedchem.1c00686 ]